☰

Peter R. Byron

Affiliations: 
Virginia Commonwealth University, Richmond, VA, United States 
Area:
Pharmaceutical Chemistry, Pharmacy
Website:
https://news.pharmacy.vcu.edu/2015/01/12/pceus-changing-of-the-guard/
Google:
"Peter Byron"
Bio:

http://news.pharmacy.vcu.edu/2016/01/15/end-of-an-era-byron-leaves-global-legacy-after-28-years-of-service/
https://www.linkedin.com/in/peter-byron-3ba6b76
Dr Peter R. Byron, BSc(Pharm), PhD, MPS, graduated with first-class honours from Manchester University school of pharmacy in 1970 and three years later completed his PhD on "Quantitation of Immune Potential in Uraemic Patients." Dr. Byron performed post-doctoral work with S.S. Davis and Robert Notari in the fields of pharmaceutics, biopharmaceutics and pharmacokinetics at the University of Aston, England (1974) and Ohio State University, Columbus, Ohio (1976).

Mean distance: (not calculated yet)
 
Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor
Robert Emil Notari post-doc 1976 Ohio State

Children

Sign in to add trainee
Masahiro Sakagami grad student 2000 VCU
Yinuo Pang grad student 2004 VCU
Michael Hindle post-doc 1994 VCU

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Wei X, Hindle M, Kaviratna A, et al. (2018) In Vitro Tests for Aerosol Deposition. VI: Realistic Testing with Different Mouth-Throat Models and In Vitro-In Vivo Correlations for a Dry Powder Inhaler, Metered Dose Inhaler, and Soft Mist Inhaler. Journal of Aerosol Medicine and Pulmonary Drug Delivery
Wei X, Hindle M, Delvadia RR, et al. (2017) In Vitro Tests for Aerosol Deposition. V: Using Realistic Testing to Estimate Variations in Aerosol Properties at the Trachea. Journal of Aerosol Medicine and Pulmonary Drug Delivery
Gomez-Arroyo J, Sakagami M, Syed AA, et al. (2015) Iloprost reverses established fibrosis in experimental right ventricular failure. The European Respiratory Journal. 45: 449-62
Li M, Byron PR. (2013) Tobramycin disposition in the rat lung following airway administration. The Journal of Pharmacology and Experimental Therapeutics. 347: 318-24
Delvadia RR, Longest PW, Hindle M, et al. (2013) In vitro tests for aerosol deposition. III: effect of inhaler insertion angle on aerosol deposition. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 26: 145-56
Delvadia R, Hindle M, Longest PW, et al. (2013) In vitro tests for aerosol deposition II: IVIVCs for different dry powder inhalers in normal adults. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 26: 138-44
Delvadia RR, Longest PW, Byron PR. (2012) In vitro tests for aerosol deposition. I: Scaling a physical model of the upper airways to predict drug deposition variation in normal humans. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 25: 32-40
Werley MS, McDonald P, Lilly P, et al. (2011) Non-clinical safety and pharmacokinetic evaluations of propylene glycol aerosol in Sprague-Dawley rats and Beagle dogs. Toxicology. 287: 76-90
Byron PR, Hindle M, Lange CF, et al. (2010) In vivo-in vitro correlations: predicting pulmonary drug deposition from pharmaceutical aerosols. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 23: S59-69
Kotian R, Peart J, Bryner J, et al. (2009) Calibration of the modified Electrical Low-Pressure Impactor (ELPI) for use with pressurized pharmaceutical aerosols. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 22: 55-65
See more...